4.5 Letter

Mutations of the gene FNIP1 associated with a syndromic autosomal recessive immunodeficiency with cardiomyopathy and pre-excitation syndrome

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 50, Issue 7, Pages 1078-1080

Publisher

WILEY
DOI: 10.1002/eji.201948504

Keywords

B cell development; cardiomyopathy; immunodeficiency; metabolism; myopathy

Categories

Funding

  1. Forderverein zugunsten krebskranker Kinder Krefeld e.V.
  2. Bundesministerium fur Bildung und Forschung (PID-NET) [BMBF 01GM1517B]
  3. Centre for Personalised Immunology - National Health and Medical Research Council of Australia, NHMRC
  4. The Australian National University, Canberra, Australia
  5. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [714226]
  6. St. Baldrick's Robert Arceci Innovations Award
  7. Deutsche Forschungsgemeinschaft

Ask authors/readers for more resources

AMPK (adenosine monophosphate-activated protein kinase) is phosphorylated (AMPK-P) in response to low energy through allosteric activation by Adenosine mono- or diphosphate (AMP/ADP). Folliculin (FLCN) and the FLCN-interacting proteins 1 and 2 (FNIP1, 2) modulate AMPK. FNIP1 deficiency patients have a AMPK-P gain of function phenotype with hypertrophic cardiomyopathy, Wolff-Parkinson-White pre-excitation syndrome, myopathy of skeletal muscles and combined immunodeficiency. (+)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available